2011Shenyang Yaoke Daxue xuebaoRequires access

Bioequivalence study on Yifuxianan tablets (II) in healthy volunteers

Yu Zhiguo

Open publisher page 0 citations

Abstract

Objective To study the bioequivalence of Yifuxianan tablets(II)(compound preparation of rifampicin,isoniazid and pyrazinamide) after a single oral dose of the tested and referred preparations to 20 healthy volunteers.Methods Concentrations of rifampicin,isoniazid and pyrazinamide in plasma were determined by RP-HPLC,pharmacokinetic parameters and relative bioavailability were calculated by using DAS software.Results The linear ranges of rifampicin,isoniazid and pyrazinamide were 0.40-25.0 mg · L-1,0.10-10.0 mg · L-1 and 0.30-60.0 mg · L-1,with good linearity(r0.99),intra-and inter-day precisions were below 15%,average recoveries of three drugs were above 70%,the relative bioavailability of rifampicin,isoniazid and pyrazinamide were(97.5±25.5)%,(108.7±24.0)% and(109.0±17.4)%,respectively.Conclusions The tested preparation is bioequivalent with the referred preparation.

About this research paper

What this paper is about

Objective To study the bioequivalence of Yifuxianan tablets(II)(compound preparation of rifampicin,isoniazid and pyrazinamide) after a single oral dose of the tested and referred preparations to 20 healthy volunteers.Methods Concentrations of rifampicin,isoniazid and pyrazinamide in plasma were determined by RP-HPLC,pharmacokinetic parameters and relative bioavailability were calculated by using DAS software.Results The linear ranges of rifampicin,isoniazid and pyrazinamide were 0.40-25.0 mg · L-1,0.10-10.0 mg · L-1 and 0.30-60.0 mg · L-1,with good linearity(r0.99),intra-and inter-day precisions were below 15%,average recoveries of three drugs were above 70%,the relative bioavailability of rifampicin,isoniazid and pyrazinamide were(97.5±25.5)%,(108.7±24.0)% and(109.0±17.4)%,respectively.Conclusions The tested preparation is bioequivalent with the referred preparation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study the bioequivalence of Yifuxianan tablets(II)(compound preparation of rifampicin,isoniazid and pyrazinamide) after a single oral dose of the tested and referred preparations to 20 healthy volunteers.Methods Concentrations of rifampicin,isoniazid and pyrazinamide in plasma were determined by RP-HPLC,pharmacokinetic parameters and relative bioavailability were calculated by using DAS software.Results The linear ranges of rifampicin,isoniazid and pyrazinamide were 0.40-25.0 mg · L-1,0.10-10.0 mg · L-1 and 0.30-60.0 mg · L-1,with good linearity(r0.99),intra-and inter-day precisions were below 15%,average recoveries of three drugs were above 70%,the relative bioavailability of rifampicin,isoniazid and pyrazinamide were(97.5±25.5)%,(108.7±24.0)% and(109.0±17.4)%,respectively.Conclusions The tested preparation is bioequivalent with the referred preparation.

Key concepts: Bioequivalence, Pyrazinamide, Rifampicin, Isoniazid, Bioavailability, Pharmacokinetics, Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence study on Yifuxianan tablets (II) in healthy volunteers — Research Paper | ScholarLens